Genistein exerts anti-leukemic effects on genetically different acute myeloid leukemia cell lines by inhibiting protein synthesis and cell proliferation while inducing apoptosis – molecular insights from an iTRAQ™ quantitative proteomics study
Acute myeloid leukemia (AML) is a form of cancer that affects the hematopoietic precursor cells with lethal effects. We investigated the prospect of using genistein as an effective alternate therapy for AML. A two-cell line model, one possessing the FLT3 gene with the ITD mutation (MV4−11) and the o...
Main Authors: | Narasimhan, Karthik, Lee, Yew Mun, Lim, Teck Kwang, Port, Sarah Alexandra, Han, Jin-Hua, Chen, Chien-Shing, Lin, Qingsong |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381704/ |
Similar Items
-
i-Tracker: For quantitative proteomics using iTRAQ™
by: Shadforth, Ian P, et al.
Published: (2005) -
Precise protein quantification based on peptide quantification using iTRAQ™
by: Boehm, Andreas M, et al.
Published: (2007) -
iTRAQ-based proteomics reveals novel biomarkers of osteoarthritis
by: Ikeda, Daiki, et al.
Published: (2013) -
Serum proteomics analysis and comparisons using iTRAQ in the progression of hepatitis B
by: PENG, LIANG, et al.
Published: (2013) -
Exploring the Nicotinic Acetylcholine Receptor-associated Proteome with iTRAQ and Transgenic Mice
by: McClure-Begley, Tristan D., et al.
Published: (2013)